Adiposity Related Diseases

  • Off-Label Obesity Treatment Alternatives for Complicated Patients (Recorded 3 CME/CE)

    CME/CE Expiration Date: 4/25/2024*

    CME/CE Expiration Date: 4/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description: 

    Obesity prevalence is at worldwide epidemic levels, and behind cigarette smoking, obesity is the second leading cause of preventable deaths. Interventions directed toward improving nutrition, increasing physical activity, and changing eating behaviors can be effective treatments for obesity, but long -term benefits are often countered by neuro-hormonally activated homeostatic mechanisms that eventually lead to weight regain. Anti-obesity pharmacologic agents are often effective in combating the internal drives that increase appetite and contribute to obesity as well as those associated with weight regain. Despite the prevalence and deadly consequences of obesity, there are currently only four FDA approved anti-obesity medications for long -term use and four older sympathomimetic agents approved only three month’s treatment duration. Pharmacologic options for obesity treatment are further limited by other factors that include medication expense and lack of insurance coverage, concurrent medical conditions, drug interactions, adverse drug effects, and individual lack of therapeutic response in some individuals.  

    Fortunately, there are options that are not FDA approved (off-label) that are generally safe and efficacious for obesity treatment backed by clinical experience and medical literature. This educational series will focus on safe and efficacious obesity treatment in challenging patients when FDA approved therapeutic agents are not an option. 

    With disease management, the weight-gain potential of medications is often not considered when choosing pharmacotherapy options. Many commonly used medications associated with weight gain have alternatives with weight neutral or weight losing effects.  Shifting medication choices from weight positive to weight neutral or negative choices can be an effective means of facilitating weight loss. 

     

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring material for a maximum of 3 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Obesity Medicine 2021 Virtual - Spring Obesity Summit (Recorded 22 CME/CE)

    CME/CE Expiration Date: 4/25/2024*

    CME/CE Expiration Date: 4/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description: 

    The theme for the 2021 Spring Obesity Summit is Treat Obesity First. Obesity is associated with hundreds of other chronic diseases, so why not address it at the root? Treating obesity first will help you better manage obesity-related conditions; it will also reduce the risk of your patients developing further complications and improve their overall health and quality of life.

    At the Spring Obesity Summit, gain practical strategies you can use to address obesity at the root in a primary care, specialty, or obesity medicine practice. Learn how to apply evidence-based guidelines to the treatment of obesity – including selecting appropriate anti-obesity medications, managing patients in post-bariatric surgery, and treating your patients’ obesity-related conditions, including non-alcoholic fatty liver disease and cardiovascular disease. 

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring material for a maximum of 22 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Challenging Cases in Obesity Medicine

    Includes Credits

    Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FAHA, FTOS, Dipl. ABOM

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    This presentation will explore the evaluation and treatment of a series of complicated cases. Dr. Stanford will present her approach to treating patients with multiple medical problems and complex case histories. This session will review real-world scenarios to provide insights and skills to enhance clinical management of patients with obesity and co-morbid conditions

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • Inequality in Infectious Disease: COVID, Obesity and Patients of Color

    Includes Credits

    Keith Ferdinand, MD, FACC, FAHA, FNLA, FASPC

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    This session will explore the virulence of COVID infections in different populations. People with obesity are more likely to develop complications of COVID-19 infections with higher hospitalization rates and mortality.  The added risk of infection complications also applies to people of color, especially those who also have obesity. Attendees will learn to recognize the specific risks COVID-19 in people of color with obesity as well as identify the role of prevention, early detection and aggressive treatment in these patients.

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • A Hot Mess – Obesity, Inflammation and CVD; Systems Thinking

    Includes Credits

    Lance Simkins, MD, FACC

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Inflammation is known to play a significant role in cardiovascular disease. Adiposopathy derived inflammation is also recognized as a key contributor in obesity-related diseases.  This session will explore the roles and relationships of inflammation, obesity and cardiovascular disease as part of a larger system.

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • Overcoming Barriers: Physical Activity in Persons with Spinal Cord Injury

    Includes Credits

    David R. Gater, MD, PhD, MS

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Attendees will participate in a series of case presentations on managing individuals with obesity and spinal cord injury (SCI).  Cases will explore specific comorbid conditions related to SCI and their impact on ability to engage in physical activity.  Participants will learn to develop specific activity regimens tailored to address mobility limitations of different levels of SCI, and customize treatment plans.  Attendees will learn to adopt strategies designed to benefit both functional mobility and weight management.

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • Coherent Management of Diabetes and Obesity

    Includes Credits

    Daen Scott, FNP-BC, BC-ADM, CDCES< CSOWM

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    This lecture will review the latest diabetes treatment guidelines which include individualized glycemic targets, medication options that address managing both diabetes and obesity, and new technologies designed to improve diabetes care. Case based examples will illustrate how  these new tools may be implemented into a busy medical practice and some of the common pitfalls that may be encountered.

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • Slashing the Fat Out in NAFLD

    Includes Credits

    Humberto Gonzalez, MD

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Non-alcoholic fatty liver disease (NAFLD) is a prevalent medical problem worldwide and frequently coexists with obesity and its associated conditions. This session will review the difference between non-alcoholic fatty liver and non-alcoholic steatohepatitis, as well as the differential diagnosis of fatty liver. Guidance on the clinical assessment of NAFLD, utilizing laboratory values, imaging studies and other preclinical tests will be reviewed, as well as the role of liver biopsy. A review of the therapeutic armamentarium with focus on the liver specific effects. Additionally, this session will review the role and effect of lifestyle and pharmacological treatment as well as more invasive interventions such as bariatric surgery and other procedures.

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • The Art and Science of Deprescribing

    Includes Credits

    Jeff Stanley, MD, Dipl. ABOM

    CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    No matter what dietary or surgical intervention is used to treat patients with obesity, knowing how to deprescribe, especially for patients with type 2 diabetes, is critical. This session will address the practical and critical skill of deprescribing medications as patients with diabetes and other metabolic disease lose weight.  

    Successful obesity medicine providers will understand that their treatment will alter the medication needs of their patients. Therefore, obesity medicine clinicians are medically, ethically, and legally required to have the necessary skills to keep patients safe. Medication deprescription is an anticipated outcome with weight loss, but there is a lack of guidelines on how to safely proceed with medication changes. This session will provide obesity providers with guidance on proper medication deprescribing

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

  • Pharmacotherapy of Complex Obesity: A Case Based Approach

    Includes Credits

    Silvana Pannain, MD

    CME/CE Expiration Date: 4/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    More than one-third of adults in the United States suffer from the chronic disease of obesity. While lifestyle modification is the cornerstone of any weight loss treatment, weight loss achieved through lifestyle modifications alone is often limited and difficult to maintain. Therefore, pharmacotherapy, when used appropriately in combination with lifestyle modification plays an important role in the treatment of obesity and improves both short-term and long-term outcomes. 

    The session will offer a case-based, practical guide to current strategies in obesity management across various conditions such as drug induced weight gain, prediabetes and type 2 diabetes, polycystic ovary syndrome, depression, binge eating, other psychiatric conditions, cardiovascular disease, suboptimal post bariatric surgery weight loss or post bariatric surgery weight regain, and monogenic obesity. Finally, the session will discuss the treatment of the patient with overweight/obesity who also has prediabetes or diabetes and recommend appropriate diabetes medications to prescribe that consider a weight centric approach.

    Accreditation:       

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

    The Obesity Medicine Association designates this internet enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.